Drugmakers slash prices in China to get on reimbursement list
Seventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis…
Author
Insomnia symptoms tied to increased risk of heart attack and stroke
Researchers followed 487,200 people in China for about a decade starting when they were 51 years old on average
FDA panel votes against Lilly-Boehringer Ingelheim’s diabetes drug
The drug, empagliflozin, was approved in 2014 in doses of 10 mg and 20 mg to help lower blood sugar levels in patients with type 2…
Lupin posts net loss of Rs 123 crore in Q2
The company had posted net profit of Rs 288.45 crore in July-September period of 2018-19
Judge shields OxyContin-maker Purdue from litigation until April
This gives time to the maker of OxyContin time to try to reach legal settlement the company says is worth $10 billion
Stada buys Takeda drug bundle to boost Russia business
The portfolio, which Takeda is selling in a push to slash debt after its $59 billion purchase of Shire, includes drugs sold…
Novartis arthritis drug fails to prove it is significantly better than rival
Novartis said Cosentyx, when used to treat active psoriatic arthritis, "narrowly missed statistical significance for superiority"…
FDA approves Biogen and Alkermes’ multiple sclerosis drug
The approval is good news for Biogen as its top-selling drug Tecfidera, also a multiple sclerosis treatment, is facing patent…
Walmart, CVS and Rite Aid pull 22-ounce J&J baby powder off shelves
CVS Health Corp said on Thursday it would remove the bottles from its online store as well, out of caution and to prevent customer…
Biogen and Eisai revive plans for Alzheimer’s drug, surprising market
The field of experimental Alzheimer’s treatments is littered with high-profile failures, with many major drugmakers abandoning the…